About
Tropical Disease Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
759
By Phase
PHASE2: 4PHASE1/PHASE2: 1
By Status
COMPLETED: 2NOT_YET_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1AVAILABLE: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06656351Lead Sponsor
B-FREE Chronic Babesiosis Study
PHASE2Not yet recruiting
40 participants
Started: Nov 30, 2025 · Completed: Sep 30, 2027
NCT06207370Lead Sponsor
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
PHASE2Recruiting
33 participants
Started: Jun 17, 2024 · Completed: Jul 1, 2025
NCT04533347Lead Sponsor
Tafenoquine in Patients With Mild to Moderate COVID-19
PHASE2Completed
86 participants
Started: Feb 19, 2021 · Completed: Jun 30, 2022
NCT02569827Collaborator
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
PHASE1/PHASE2Withdrawn
Started: Dec 31, 2018 · Completed: Aug 8, 2019
NCT03320174Lead Sponsor
Long-Term Safety Study of Tafenoquine
PHASE2Completed
600 participants
Started: Oct 5, 2017 · Completed: Jul 13, 2021
Locations (1)
Headquarters
Washington, DC, United States
Map
Loading map...